Additionally, loss of ATRX induces an immunosuppressive microenvironment in gliomas by promoting the secretion of immunosuppressive cytokines and upregulating the expression of immune checkpoint molecules, suppressing anti‐tumor immunity.72 This evidence concerns the gene ATRX and central nervous system cancer.